Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Induction of myelodysplasia by myeloid-derived suppressor cells.

Chen X, Eksioglu EA, Zhou J, Zhang L, Djeu J, Fortenbery N, Epling-Burnette P, Van Bijnen S, Dolstra H, Cannon J, Youn JI, Donatelli SS, Qin D, De Witte T, Tao J, Wang H, Cheng P, Gabrilovich DI, List A, Wei S.

J Clin Invest. 2013 Nov 1;123(11):4595-611.

PMID:
24216507
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.

Lechner MG, Megiel C, Russell SM, Bingham B, Arger N, Woo T, Epstein AL.

J Transl Med. 2011 Jun 9;9:90. doi: 10.1186/1479-5876-9-90.

PMID:
21658270
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.

Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, Srikrishna G.

J Immunol. 2008 Oct 1;181(7):4666-75.

PMID:
18802069
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.

Gleason MK, Ross JA, Warlick ED, Lund TC, Verneris MR, Wiernik A, Spellman S, Haagenson MD, Lenvik AJ, Litzow MR, Epling-Burnette PK, Blazar BR, Weiner LM, Weisdorf DJ, Vallera DA, Miller JS.

Blood. 2014 May 8;123(19):3016-26. doi: 10.1182/blood-2013-10-533398. Epub 2014 Mar 20.

PMID:
24652987
[PubMed - indexed for MEDLINE]
5.

Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions.

Zhou J, Wu J, Chen X, Fortenbery N, Eksioglu E, Kodumudi KN, Pk EB, Dong J, Djeu JY, Wei S.

Int Immunopharmacol. 2011 Jul;11(7):890-8. doi: 10.1016/j.intimp.2011.01.007. Epub 2011 Jan 15.

PMID:
21244860
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.

Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM, Ortiz M, Nacken W, Sorg C, Vogl T, Roth J, Gabrilovich DI.

J Exp Med. 2008 Sep 29;205(10):2235-49. doi: 10.1084/jem.20080132. Epub 2008 Sep 22.

PMID:
18809714
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

S100A8/A9 activate key genes and pathways in colon tumor progression.

Ichikawa M, Williams R, Wang L, Vogl T, Srikrishna G.

Mol Cancer Res. 2011 Feb;9(2):133-48. doi: 10.1158/1541-7786.MCR-10-0394. Epub 2011 Jan 12. Erratum in: Mol Cancer Res. 2011 Sep;9(9):1266.

PMID:
21228116
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation.

Sade-Feldman M, Kanterman J, Ish-Shalom E, Elnekave M, Horwitz E, Baniyash M.

Immunity. 2013 Mar 21;38(3):541-54. doi: 10.1016/j.immuni.2013.02.007. Epub 2013 Mar 7.

PMID:
23477736
[PubMed - indexed for MEDLINE]
Free Article
9.

Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.

Zhang B, Wang Z, Wu L, Zhang M, Li W, Ding J, Zhu J, Wei H, Zhao K.

PLoS One. 2013;8(2):e57114. doi: 10.1371/journal.pone.0057114. Epub 2013 Feb 20.

PMID:
23437326
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.

Görgün GT, Whitehill G, Anderson JL, Hideshima T, Maguire C, Laubach J, Raje N, Munshi NC, Richardson PG, Anderson KC.

Blood. 2013 Apr 11;121(15):2975-87. doi: 10.1182/blood-2012-08-448548. Epub 2013 Jan 15.

PMID:
23321256
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow.

Ramachandran IR, Martner A, Pisklakova A, Condamine T, Chase T, Vogl T, Roth J, Gabrilovich D, Nefedova Y.

J Immunol. 2013 Apr 1;190(7):3815-23. doi: 10.4049/jimmunol.1203373. Epub 2013 Mar 4.

PMID:
23460744
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.

Lechner MG, Liebertz DJ, Epstein AL.

J Immunol. 2010 Aug 15;185(4):2273-84. doi: 10.4049/jimmunol.1000901. Epub 2010 Jul 19. Erratum in: J Immunol. 2010 Nov 1;185(9):5668.

PMID:
20644162
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.

Zhou L, Nguyen AN, Sohal D, Ying Ma J, Pahanish P, Gundabolu K, Hayman J, Chubak A, Mo Y, Bhagat TD, Das B, Kapoun AM, Navas TA, Parmar S, Kambhampati S, Pellagatti A, Braunchweig I, Zhang Y, Wickrema A, Medicherla S, Boultwood J, Platanias LC, Higgins LS, List AF, Bitzer M, Verma A.

Blood. 2008 Oct 15;112(8):3434-43. doi: 10.1182/blood-2008-02-139824. Epub 2008 May 12.

PMID:
18474728
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

MDS-like experimental myelodysplasia: multilineage abnormal hematopoiesis in transgenic mice harboring the SV40 large T antigen under an immunoglobulin enhancer.

Furuta Y, Aizawa S, Suda Y, Ikawa Y, Nishikawa S, Hayashi S, Hirabayashi Y, Inoue T.

Exp Hematol. 1993 Jun;21(6):806-15.

PMID:
8500578
[PubMed - indexed for MEDLINE]
15.

Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo.

Abdel-Wahab O, Gao J, Adli M, Dey A, Trimarchi T, Chung YR, Kuscu C, Hricik T, Ndiaye-Lobry D, Lafave LM, Koche R, Shih AH, Guryanova OA, Kim E, Li S, Pandey S, Shin JY, Telis L, Liu J, Bhatt PK, Monette S, Zhao X, Mason CE, Park CY, Bernstein BE, Aifantis I, Levine RL.

J Exp Med. 2013 Nov 18;210(12):2641-59. doi: 10.1084/jem.20131141. Epub 2013 Nov 11.

PMID:
24218140
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Innate immune signaling in the myelodysplastic syndromes.

Starczynowski DT, Karsan A.

Hematol Oncol Clin North Am. 2010 Apr;24(2):343-59. doi: 10.1016/j.hoc.2010.02.008. Review.

PMID:
20359630
[PubMed - indexed for MEDLINE]
17.

miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling.

Bhagat TD, Zhou L, Sokol L, Kessel R, Caceres G, Gundabolu K, Tamari R, Gordon S, Mantzaris I, Jodlowski T, Yu Y, Jing X, Polineni R, Bhatia K, Pellagatti A, Boultwood J, Kambhampati S, Steidl U, Stein C, Ju W, Liu G, Kenny P, List A, Bitzer M, Verma A.

Blood. 2013 Apr 11;121(15):2875-81. doi: 10.1182/blood-2011-12-397067. Epub 2013 Feb 6.

PMID:
23390194
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

S100A9 a new marker for monocytic human myeloid-derived suppressor cells.

Zhao F, Hoechst B, Duffy A, Gamrekelashvili J, Fioravanti S, Manns MP, Greten TF, Korangy F.

Immunology. 2012 Jun;136(2):176-83. doi: 10.1111/j.1365-2567.2012.03566.x.

PMID:
22304731
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma.

Melani C, Sangaletti S, Barazzetta FM, Werb Z, Colombo MP.

Cancer Res. 2007 Dec 1;67(23):11438-46.

PMID:
18056472
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site.

Haverkamp JM, Crist SA, Elzey BD, Cimen C, Ratliff TL.

Eur J Immunol. 2011 Mar;41(3):749-59. doi: 10.1002/eji.201041069. Epub 2011 Feb 2.

PMID:
21287554
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk